NEUPHORIA THERAPEUTICS INC (NEUP) Stock Analyst Ratings
NASDAQ:NEUP - US64136E1029 - Common Stock
13.92 USD
-1.18 (-7.78%)
ChartMill assigns a Buy % Consensus number of 83% to NEUP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 53.88% above the current price.
NEUP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NEUP.
In the previous month the buy percentage consensus was at a similar level.
NEUP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |